Signet Financial Management’s Zimmer Biomet ZBH Stock Holding History

Signet Financial Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-124	Closed	-$15K	–	1377
2021 Q4	$15K	Buy	+124	New	+$16.2K	﹤0.01%	964
2018 Q4	–	Sell	-124	Closed	-$16K	–	862
2018 Q3	$16K	Hold	124	–	–	﹤0.01%	555
2018 Q2	$13K	Hold	124	–	–	﹤0.01%	597
2018 Q1	$13K	Buy	+124	New	+$14.4K	﹤0.01%	543

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Signet Financial Management's ZBH Position: Q1 2022 in Review

Signet Financial Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 124 shares — an estimated $15K sold.

Signet Financial Management first reported a position in ZBH in Q1 2018 and held it in 4 quarters. The position peaked at $16K in Q3 2018. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Signet Financial Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Signet Financial Management sold 124 Zimmer Biomet shares in Q1 2022, an estimated $15K.
Signet Financial Management first reported a position in Zimmer Biomet in Q1 2018 and held it in 4 quarters.
Signet Financial Management's Zimmer Biomet position peaked at $16K in Q3 2018.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.